References
1. Northway HW, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline-membrane disease - brochopulmonary dyslasia. N Engl J Med 1967; 276(1967):357-368
2. Thébaud B, Goss KN, Laughon M, Whitsett JA, Abman SH, Steinhorn RH, Aschner JL, Davis PG, McGrath-Morrow SA, Soll RF, et al.Bronchopulmonary dysplasia. Nat Rev Dis Prim 2019; 5(1):1-23
3. Thekkeveedu RK, Guaman MC, Shivanna B. Bronchopulmonary dysplasia review pathophysiology. Respir Med 2017;132(3):170-177
4. Nelin LD, Bhandari V. How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow”.F1000Res 2017; 6:539
5. Jensen EA, Foglia EE, Schmidt B. Evidence-based pharmacologic therapies for prevention of bronchopulmonary dysplasia – Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology. Clin Perinatol 2015; 42(4):755-779
6. Filippone M, Nardo D, Bonadies L, Salvadori, S,Baraldi E. Update on postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Am J Perinatol 2019; 36:S58-S62
7. Demauro SB, Dysart K, Kirpalani H. Stopping the swinging pendulum of postnatal corticosteroid use. J. Pediatr 2014;164(1):9-11
8. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants effect modification by risk for chronic lung disease.Pediatrics 2005;115(3):655-661
9. Doyle LW Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. J Pediatr 2014; 165(6):1258-1260
10. Laughon MM, Langer JC, Bose CL, Smith PB, Ambalavanan N, Kennedy KA, Stoll BJ, Buchter S, Laptook AR, Ehrenkranz RA et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am Respir and Crit Care Med 2011; 183(12):1715-1722
11. Doyle LW, Cheong JLY. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia – Who might benefit? Semin Fetal Neonatal Med 2017; 22(5):290-295
12. Villar J, Cheikh I, Victora CG, Ohuma EO, Bertino E, Altman DG, Lambert A, Papageorghiou AT, Carvalho M, Jaffer YA et al . International standards for newborn weight, length, and head circumference by gestational age and sex: The Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). Lancet2014; 384(9946):857-68. https://doi.org/10.1016/s0140-6736(14)60932-6
13. Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987; 17(4):213-88
14. Jobe AH, Bancalari E. Bronchopulmonary Dysplasia. NICHD / NHLBI / ORD Workshop Summary. Am Respir and Crit Care Med2001;163:1723-1729
15. Bancalari E, Claure N, Sosenko IRS. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003; 8(1):63-71
16. Lapcharoensap W, Gage SC, Kan P, Profit J, Shaw GM, Gould JB, Stevenson DK, O’Brodovich H, Lee HC. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr 2015; 169(2): e143676
17. Shah PS, Lui K, Sjörs G, Mirea L, Reichman B, Adams M, Modi N, Darlow BA, Kusuda S, San Feliciano L et al . Neonatal outcomes of very low birth weight and very preterm neonates: an international comparison. J Pediatr 2016; 177:144-152
18. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sánchez P, Meurs KPV, Wyckoff M et al . Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2016;314(10):1039-1051
19. Abman SH, Bancalari E, Jobe A. The evolution of bronchopulmonary dysplasia after 50 years. Am Respir and Crit Care Med 2017; 195(4):421-424
20. Siffel C, Kistler KD, Lewis JFM, Sarda SP. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med 2021; 34(11):1721-1731
21. Rede Brasileira de Pesquisas Neonatais (2021) Mortalidade em recém-nascidos de muito baixo peso nos 20 centros da RBPN : 2011 a 2019. https://redeneonatal.com.br/blog-rbpn/nossos-dados/mortalidade/. Accessed 29 November 2022
22. Glaser K, Speer CP. Pre and postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. In: Bhandari VBronchopulmonary dysplasia , 2016; Philadelphia, p 55-77
23. Bhering CA, Mochdece CC, Moreira MEL, Rocco JR, Sant’Anna GM. Bronchopulmonary dysplasia prediction model for 7-day-old infants.J Pediatr (Rio J) 2007; 83(2):163-170
24. Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, Ryan RM, Kallapur SG, Steinhorn RH, Konduri GG et al . Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr 2018; 197:300-308
25. Jiang S, Yang Z, Shan R, Zhang Y, Yan W, Yang Y, Shah PS, Lee SK, Cao Y. Neonatal outcomes following culture-negative late-onset sepsis among preterm infants. Pediatr Infect Dis J 2020; 39(3):232-238
26. Romagnoli C, Zecca E, Tortorolo L, Vento G, Tortorolo G. A scoring system to predict the evolution of respiratory distress syndrome into chronic lung disease in preterm infants. Intensive Care Med 1998; 24(5):476-480
27. Kim Yd, Kim Ea, Kim Ks, Pi SY, Kang W. Scoring method for early prediction of neonatal chronic lung disease using modified respiratory parameters. J Korean Med Sci 2005; 20:397-401
28. Ryan SW, Nycyk J, Shaw BNJ. Prediction of chronic neonatal lung disease on day 4 of life. Eur J Pediatr 1996; 155:668-671
29. Sharma A, Xin Y, Chen X, Sood BG. Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants.Pediatr Neonatol 2020; 61(3):290-299
30. Zhang J, Luo C, Lei M, Shi Z, Cheng X, Wang L, Shen M, Zhang Y, Zhao M, Wang L et al . Development and validation of a nomogram for predicting bronchopulmonary dysplasia in very-low-birth-weight infants.Front Pediatr 2021; 9:1-9
31. El Faleh, Faouzi M, Adams M, Gerull R, Chnayna J, Giannoni E, Roth-Kleiner M. Bronchopulmonary dysplasia: a predictive scoring system for very low birth weight infants: a diagnostic accuracy study with prospective data collection. Eur J Pediatr 2021; 180(8):2453-2461.
32. Kruczek P, Krajewski P, Hozejowski R, Szczapa T. FiO2 before surfactant, but not time to surfactant, affects outcomes in infants with respiratory distress syndrome. Front Pediatr 2021; 9:1-7
33. Muniz JO. Preto no branco? mensuração, relevância e concordância classificatória no país da incerteza racial. Dados 2012; 55(1):251-282
34. Greenberg RG, McDonald SA, Laughon MM, Tanaka D, Jensen E, Meurs KV, Eichenwald E, Brumbaugh J, Duncan A, Walsh M et al . Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterms infants. Arch Dis Child. Fetal Neonatal Ed2022; 107:F638-F643
35. Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, Kirpalani H, Laughon MM, Poindexter BB, Duncan AF et al . The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach. Am Respir and Crit Care Med 2019; 200(6):751-759
36. Gursoy T, Hayran M, Derin H, Ovali F. A clinical scoring system to predict the development of bronchopulmonary dysplasia. Am J Perinatol 2015; 32(7):659-666
37. Laughon M, Allred EN, Bose C, O’Shea TM, Marter LJV, Ehrenkranz RA, Leviton A. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 2009; 123(4):1124-1131
38. Nobile S, Marchionni P, Vento G, Vendettuoli V, Marabini C, Romagnoli C, Carnielli V. New insights on early patterns of respiratory disease among extremely low gestational age newborns. Neonatology2017; 112(1):53-59
39. Rede Brasileira de Pesquisas Neonatais (2022) Missão . https://redeneonatal.com.br/missao/. Acessed 29 November 2022
40. Onland W, Debray TP, Laughon MM, Miedema M, Cools F, Askie LM, Asselin JM, Calvert SA, Courtney SE, Dani C et al . Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study. BMC Pediatr 2013; 13(1)
Table 1 –Mathematic model for prediction of bronchopulmonary dysplasia tailored with local population and National Institute of Child ­­­­Health and Human Development tool (NICHD)